These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 23383564

  • 1. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M, Bartuzi A, Kulik-Rechberger B, Rechberger T.
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recognizing and treating urogenital atrophy in postmenopausal women.
    Goldstein I.
    J Womens Health (Larchmt); 2010 Mar; 19(3):425-32. PubMed ID: 20156082
    [Abstract] [Full Text] [Related]

  • 5. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen.
    Simon JA.
    J Womens Health (Larchmt); 2011 Oct; 20(10):1453-65. PubMed ID: 21819250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV, Bushmakin AG, Komm BS, Abraham L.
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [Abstract] [Full Text] [Related]

  • 12. Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction.
    Santoro N, Worsley R, Miller KK, Parish SJ, Davis SR.
    J Sex Med; 2016 Mar; 13(3):305-16. PubMed ID: 26944462
    [Abstract] [Full Text] [Related]

  • 13. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF, Kimble TD, Lin FDY, Battucci S, Sniukiene V, Liu JH.
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study.
    Fernandes T, Pedro AO, Baccaro LF, Costa-Paiva LH.
    Menopause; 2018 Jun; 25(6):641-647. PubMed ID: 29462095
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I, Alexander JL.
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [Abstract] [Full Text] [Related]

  • 19. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2007 Sep; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.